Skip to main content

Meet the Analyst: Dr. Tara Speranza, Bell Potter Analyst Part 2

Grady Wulff
February 23, 2023

Continue on to learn about the remaining stocks, Microba Life Sciences (ASX:MAP) and Monash IVF (ASX:MVF), as well as what to expect from these companies in 2023.

In this video, Dr. Tara discusses:
– (0:34) Impacts of Ferring’s FDA approval on Microba
– (5:30) Drivers behind Microba’s increase in revenue
– (7:12) What 2023 looks like for Monash IVF
– (8:39) Monash IVF’s rating
– (11:45) Monash IVF’s impact from legal action

Note: This interview was filmed on 7 February 2023.

Morning Bell 5 September

Grady Wulff
September 5, 2023

Morning Bell 4 September

Grady Wulff
September 4, 2023

Weekly Wrap 1 September

Grady Wulff
September 1, 2023

Morning Bell 1 September

Sophia Mavridis
September 1, 2023

Morning Bell 31 August

Grady Wulff
August 31, 2023

Morning Bell 30 August

Grady Wulff
August 30, 2023

Morning Bell 29 August

Sophia Mavridis
August 29, 2023

Morning Bell 28 August

Grady Wulff
August 28, 2023

Weekly Wrap 25 August

Grady Wulff
August 25, 2023

Morning Bell 25 August

Sam Kanaan
August 25, 2023

Morning Bell 24 August

Grady Wulff
August 24, 2023